As detection techniques, have become more sophisticated, both in animals and in human, so have doping processes and dopants. Increasingly these sport performance enhancing substances are minimally modified endogenous molecules, perhaps even gene therapy, that escape detection by current methodologies. The use of biomarkers, that potentially target a particular biological process, is amongst the most promising approaches in the fight against doping. The search for such novel markers utilizing big data and the omics platforms, and their validation has proved challenging. The extent to which this approach has been successful and the potential of using biomarkers for detecting doping in sport has been realized is the premise of this year’s symposium. Again, following on from discussions in the previous symposium the aim is to compare and contrast biomarkers of dopants, their nature and detection, in animals as opposed to humans. To facilitate this discourse, experts from both human and animal Anti-Doping arenas, veterinarians and scientists will be brought together.
The ADLQ Annual Symposium will take place on the 2nd and 3rd of May 2017 in Doha.
Abstract submission opens on the 1st February and closes at midnight local time on the 15th March 2017. The meeting is currently being considered for CME accreditation.
This symposium promises to offer new insights into the most recent research findings in the field of biomarkers in doping. We wish all participants a productive and engaging meeting and invite you all to experience Qatari hospitality. We are confident that you will take home significant new scientific information along with fond memories of your time in Doha.